Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.37 |
| ▸ | STAT3 | P40763 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.34 |
| ▸ | CES2 | O00748 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CASP6 | P55212 | 1/20 | 0.31 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL4324703 | 0.87 | LMNA (0.53) | LMNAPTPN1ALOX15CYP3A4MEN1 | |
| SCHEMBL937050 | 0.87 | LMNA (0.60) | LMNAPTPN1ALOX15CYP3A4TSHR | |
| SCHEMBL937318 | 0.87 | LMNA (0.60) | LMNAPTPN1ALOX15CYP3A4TSHR | |
| SCHEMBL1037667 | 0.87 | LMNA (0.60) | LMNAPTPN1ALOX15CYP3A4TSHR | |
| Hydrochloric Acid SCHEMBL937999 | 0.85 | LMNA (0.58) | LMNAPTPN1ALOX15CYP3A4MEN1 | |
| Hydrochloric Acid SCHEMBL4354664 | 0.85 | LMNA (0.58) | LMNAPTPN1ALOX15CYP3A4MEN1 | |
| Ethylene SCHEMBL27605005 | 0.83 | LMNA (0.61) | LMNAPTPN1ALOX15CYP3A4MEN1 | |
| Ethylenediamine SCHEMBL3332646 | 0.82 | LMNA (0.51) | LMNAPTPN1ALOX15CYP3A4MEN1 | |
| Propylene Glycol SCHEMBL4322377 | 0.81 | LMNA (0.47) | LMNAPTPN1ALOX15CYP3A4MEN1 | |
| SCHEMBL3333211 | 0.77 | LMNA (0.46) | LMNAPTPN1ALOX15CYP3A4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7615656-B2 | Cycloaliphatic polyepoxy compounds and preparation thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2009-11-10 | — | — | US | disclosed |
| US-7429622-B2 | Active ray curable ink-jet composition, image forming method using the same, ink-jet recording apparatus, and triarylsulfonium salt compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-09-30 | — | — | US | disclosed |
| US-20080004425-A1 | Cycloaliphatic polyepoxy compounds and prepartation thereof | DAICEL CHEMICAL INDUSTRIES, LTD. | 2008-01-03 | — | — | US | disclosed |
| EP-1873149-A1 | Cycloaliphatic polyepoxy compounds and preparation thereof | Daicel Chemical Industries, Ltd. (JP) | 2008-01-02 | — | — | EP | disclosed |
| US-7244473-B2 | Active ray curable ink-jet composition, image forming method using the same, ink-jet recording apparatus, and triarylsulfonium salt compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-07-17 | — | — | US | disclosed |
| US-20070054974-A1 | Active ray curable ink-jet composition, image forming method using the same, ink-jet recording apparatus, and triarylsulfonium salt compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-03-08 | — | — | US | disclosed |
| US-20060264529-A1 | ACTIVE ENERGY RAY CURABLE COMPOSITION | KONICA MINOLTA HOLDINGS, INC. (JP) | 2006-11-23 | — | — | US | disclosed |
| US-20040244641-A1 | Active ray curable ink-jet composition, image forming method using the same, ink-jet recording apparatus, and triarylsulfonium salt compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2004-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040244641-A1 | Active ray curable ink-jet composition, image forming method using the same, ink-jet recording apparatus, and triarylsulfonium salt compound | JAK1, INO80, ROR1 | LMNA 4608/4885PTPN1 165/4885ALOX15 1225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.